Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL622693 | 0.86 | — | — | |
| SCHEMBL18079409 | 0.84 | — | — | |
| SCHEMBL18079405 | 0.83 | ACHE (0.33) | ACHE | |
| SCHEMBL18079412 | 0.82 | — | — | |
| SCHEMBL18079411 | 0.80 | ACHE (0.32) | ACHE | |
| SCHEMBL18079635 | 0.79 | ACHE (0.31) | ACHE | |
| SCHEMBL29044951 | 0.77 | ACHE (0.31) | ACHE | |
| SCHEMBL6584289 | 0.77 | — | — | |
| SCHEMBL18079406 | 0.73 | — | — | |
| SCHEMBL17241542 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 350 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240279508-A1 | NOVEL DUAL CURE 3D PRINTING RESINS | STRATASYS INC. | 2024-08-22 | — | — | US | claimed |
| EP-4363467-A1 | NOVEL DUAL CURE 3D PRINTING RESINS | Stratasys, Inc. (US) | 2024-05-08 | — | — | EP | claimed |
| WO-2023278201-A1 | NOVEL DUAL CURE 3D PRINTING RESINS | COVESTRO LLC (US) | 2023-01-05 | — | — | WO | claimed |
| US-20220411563-A1 | NOVEL DUAL CURE 3D PRINTING RESINS | STRATASYS INC. | 2022-12-29 | — | — | US | claimed |
| US-20220119569-A1 | Curable and Solvent Soluble Formulations and Methods of Making and Using Therof | POLY6 TECHNOLOGIES, INC. | 2022-04-21 | — | — | US | claimed |
| US-20200146960-A1 | Antiperspirant and Deodorant Compositions | PROCTER & GAMBLE (US) | 2020-05-14 | — | — | US | claimed |
| US-10568825-B2 | Antiperspirant and deodorant compositions | THE PROCTER & GAMBLE COMPANY (US) | 2020-02-25 | — | — | US | claimed |
| US-20170267944-A1 | FRAGRANCE COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-09-21 | — | — | US | claimed |
| US-9422498-B2 | Low viscosity, low volatility lubricating oil basestocks | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-08-23 | — | — | US | claimed |
| US-9422499-B2 | Low viscosity, low volatility lubricating oil basestocks | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-08-23 | — | — | US | claimed |
| US-20140179748-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-26 | — | — | US | claimed |
| WO-2014093748-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| WO-2014093828-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-20140170102-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMAPNY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093807-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-20140170194-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| EP-0764179-A1 | OXIMINO SILANE TERMINATED POLYMERS AND ELASTOMERS FORMED THEREFROM | AlliedSignal Inc. (US) | 1997-03-26 | — | — | EP | claimed |
| WO-1995033784-A1 | OXIMINO SILANE TERMINATED POLYMERS AND ELASTOMERS FORMED THEREFROM | ALLIEDSIGNAL INC. (US) | 1995-12-14 | — | — | WO | claimed |
| EP-0268039-B1 | 3-TERT-BUTYL AND 3-TERT-BUTYL-5-ALKYL-4-HYDROXYPHENYL ALCANOID ACID ESTER WITH OXYETHYLATES OF POLYTHIOLS, PROCESS FOR THEIR PREPARATION AND USE AS STABILIZER | HÜLS AKTIENGESELLSCHAFT (DE) | 1992-09-02 | — | — | EP | claimed |
| US-4293406-A | Synergistic promoter combination for zinc sulfide ores | AMERICAN CYANAMID COMPANY (US) | 1981-10-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10568825-B2 | Antiperspirant and deodorant compositions | DEK, QDPR, GPX4 | ACHE 463/4885 |
| US-20140170102-A1 | Antiperspirant and Deodorant Compositions | DEK, QDPR, GPX4 | ACHE 463/4885 |
| US-20200146960-A1 | Antiperspirant and Deodorant Compositions | DEK, QDPR, GPX4 | ACHE 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.